Publications by authors named "Tim Bognar"

Claim this Profile
T
Therapeutic Drug Monitoring Versus Fixed-Interval Dosing of Dalbavancin in Implant-Associated Spinal Infections: Grand Round/A Case Study.
Jeroen P A Houwen, Charlotte S Hakkers, Valentijn A Schweitzer, Tim Bognàr, Martha L Toren-Wielema

Ther Drug Monit· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Model-Informed Precision Dosing of Busulfan for Children and Adults Undergoing Allogeneic Hematopoietic Stem Cell Transplantation: A Critical Evaluation of Current PK Models and Dose Recommendations.
Rashudy F Mahomedradja, Tim Bognàr, Kaj E van Schie, Ilse T Kuipers, Moniek A de Witte

Clin Pharmacol Ther· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing Allogeneic Hematopoietic Cell Transplantation Outcomes Through Busulfan PK/PD.
Imke H Bartelink, Arief Lalmohamed, Tim Bognar, Erfan Nur, Jaap Jan Boelens

Transplant Cell Ther· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of standard fludarabine dosing and corresponding exposures in infants and young children undergoing hematopoietic cell transplantation.
Julia Möhlmann, Lisanne van der Ploeg, Jurgen Langenhorst, Tim Bognàr, Kim van der Elst

Bone Marrow Transplant· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Lamotrigine Plasma Concentrations With Efficacy and Toxicity in Patients With Epilepsy: A Retrospective Study.
Ze-Ning Lee, Merel van Nuland, Tim Bognàr, Frans S S Leijten, Kim C M van der Elst

Ther Drug Monit· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of busulfan exposure and outcomes after HCT for patients with an inborn error of immunity.
Tim Bognàr, Moises Garcia-Rosa, Arief Lalmohamed, Tayfun Güngör, Mathias Hauri-Hohl

Blood Adv· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing accuracy of ChatGPT in response to questions from day to day pharmaceutical care in hospitals.
Merel van Nuland, Anne-Fleur H Lobbezoo, Ewoudt M W van de Garde, Maikel Herbrink, Inger van Heijl

Explor Res Clin Soc Pharm· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Busulfan target exposure attainment in children undergoing allogeneic hematopoietic cell transplantation: a single day versus a multiday therapeutic drug monitoring regimen.
T Tim Bognàr, J S Jurjen Kingma, E H Erin Smeijsters, K C M Kim van der Elst, C T M Klaartje de Kanter

Bone Marrow Transplant· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association Between the Magnitude of Intravenous Busulfan Exposure and Development of Hepatic Veno-Occlusive Disease in Children and Young Adults Undergoing Myeloablative Allogeneic Hematopoietic Cell Transplantation.
Tim Bognàr, Imke H Bartelink, Toine C G Egberts, Carin M A Rademaker, A Birgitta Versluys

Transplant Cell Ther· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unbound Fraction of Clozapine Significantly Decreases with Elevated Plasma Concentrations of the Inflammatory Acute-Phase Protein Alpha-1-Acid Glycoprotein.
Wai Hong Man, Ingeborg Wilting, Eibert R Heerdink, Gerard W K Hugenholtz, Tim Bognár

Clin Pharmacokinet· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis